Legal Briefs: AstraZeneca Wins Seroquel Suit, King Settles With DoJ, Sanofi Resolves Gender Discrimination Suit

AstraZeneca wins first Seroquel product liability trial: A New Jersey state court jury reached a verdict in favor of AstraZeneca, rejecting a plaintiff's claims that the antipsychotic caused his diabetes. The case, Baker v. AstraZeneca, is the first to go to trial. AstraZeneca is facing more than 14,000 Seroquel (quetiapine) lawsuits involving more than 22,000 plaintiffs alleging the company failed to adequately warn of the risk of diabetes. Nine previous cases set for trial were dismissed. The company said that in these cases and in the Baker suit, the facts showed that the plaintiffs either already had diabetes or had so many pre-existing risk factors that they had a significantly increased risk of diabetes before taking Seroquel